Expanding the use of primaquine for the radical cure of Plasmodium vivax

Expanding the use of primaquine for the radical cure of Plasmodium vivax

There is currently strong impetus for global malaria eradication with many National Malaria Control Programs setting ambitious elimination targets. Whilst intensified malaria control efforts have reduced the burden of falciparum malaria significantly, the fragile gains made thus far remain vulnerabl...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Price, RN, Douglas, NM
Format:	Journal article
Język:	English
Wydane:	Oxford University Press 2018

Podobne zapisy

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
od: John, G, i wsp.
Wydane: (2012)

Primaquine radical cure of <it>Plasmodium vivax</it>: a critical review of the literature
od: John George K, i wsp.
Wydane: (2012-08-01)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
od: Abla, N, i wsp.
Wydane: (2024)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
od: Nada Abla, i wsp.
Wydane: (2024-09-01)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
od: Yilma, D, i wsp.
Wydane: (2023)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
od: Setyadi, A, i wsp.
Wydane: (2019)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
od: Taylor, WRJ, i wsp.
Wydane: (2023)

Progress towards safer and more effective radical cure of Plasmodium vivax
od: Price, RN
Wydane: (2024)

Primaquine for plasmodium vivax malaria treatment – authors' reply
od: Price, RN, i wsp.
Wydane: (2020)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
od: Walter R J Taylor, i wsp.
Wydane: (2023-09-01)

Improving the radical cure of Plasmodium vivax malaria.
od: Price, R
Wydane: (2014)

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
od: Jasmine M. Olvany, i wsp.
Wydane: (2022-11-01)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
od: Yilma, D, i wsp.
Wydane: (2021)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
od: Pukrittayakamee, S, i wsp.
Wydane: (2010)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
od: Thriemer, K, i wsp.
Wydane: (2020)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
od: Taylor, WRJ, i wsp.
Wydane: (2019)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
od: Watson, J, i wsp.
Wydane: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
od: James Watson, i wsp.
Wydane: (2018-04-01)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
od: Rahmalia, A, i wsp.
Wydane: (2019)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
od: Douglas, NM, i wsp.
Wydane: (2017)

Burden and clinical characteristics of recurrent Plasmodium vivax infections, and impact of primaquine for radical cure: a systematic scoping review in India
od: Loick Pradel Kojom Foko, i wsp.
Wydane: (2024-12-01)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
od: Taylor, WR, i wsp.
Wydane: (2021)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
od: Walter Robert Taylor, i wsp.
Wydane: (2021-09-01)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
od: Agus Setyadi, i wsp.
Wydane: (2019-04-01)

Treatment of primaquine-resistant Plasmodium vivax malaria.
od: Luzzi, G, i wsp.
Wydane: (1992)

Primaquine as anti-relapse therapy for Plasmodium vivax
od: Baird, J
Wydane: (1998)

TREATMENT OF PRIMAQUINE-RESISTANT PLASMODIUM-VIVAX MALARIA
od: Luzzi, G, i wsp.
Wydane: (1992)

Single-dose radical cure of Plasmodium vivax: a step closer.
od: Price, R, i wsp.
Wydane: (2014)

Single-dose radical cure of Plasmodium vivax: A step closer
od: Price, R, i wsp.
Wydane: (2014)

Declining burden of plasmodium vivax in a population in Northwestern Thailand from 1995 to 2016 before comprehensive primaquine prescription for radical cure
od: Chu, CS, i wsp.
Wydane: (2019)

Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
od: Manju Rahi, i wsp.
Wydane: (2023-06-01)

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
od: Thriemer, K, i wsp.
Wydane: (2022)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
od: Pavani Reddy, i wsp.
Wydane: (2006-11-01)

Linked-evidence modelling of qualitative G6PD testing to inform low- and intermediate-dose primaquine treatment for radical cure of Plasmodium vivax.
od: Michelle L Gatton
Wydane: (2024-09-01)

Primaquine induced haemolysis in G6PD heterozygous females treated for the radical cure of Plasmodium vivax malaria: a nested cohort study
od: Chu, C, i wsp.
Wydane: (2017)

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
od: Kamala Thriemer, i wsp.
Wydane: (2021-04-01)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
od: Baird, J
Wydane: (2018)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
od: Watson, J, i wsp.
Wydane: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
od: Llanos-Cuentas, A, i wsp.
Wydane: (2019)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
od: Baird, J, i wsp.
Wydane: (1995)